Cytokine-blocking monoclonal antibody helps prevent asthma exacerbations
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...
Using viruses to outsmart antibiotic-resistant bacteria
Phage therapy – the treatment of bacterial infections with viruses that attack those bacteria – was used in the...
Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Current and future paradigms in the management of Esophageal Cancer
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
Metastasis Prevention – A New Weapon in the Fight Against Cancer
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
Clinical flow cytometry in cancer diagnosis and immune system disorders
Flow cytometry is a technique in which tens of thousands of cells are passed through a fluidics system, and...
Potential New Targets to Treat Acute Myeloid Leukemia
Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...
FDA Approves First Trial of CRISPR for Sickle Cell Disease
The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...
A new device for mild sleep apnea
Most non-surgical options for managing mild sleep apnea simply keep the airway open while the individual sleeps. A new...